ID   Mel KG
AC   CVCL_B6LQ
SY   KG
DR   cancercelllines; CVCL_B6LQ
DR   Wikidata; Q112129277
RX   Patent=RU2362805;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 699D.
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Transfected with: HGNC; 2434; CSF2.
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6KB ! Mel Kor
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 5
//
RX   Patent=RU2362805;
RA   Berezhnoy A.E., Larin S.S., Gnuchev N.V., Georgiev G.P., Zakharova E.S.,
RA   Baryshnikov A.Y., Demidov L.V., Mikhailova I.N., Burova O.S.,
RA   Morozova L.F., Kozlov A.M.;
RT   "Line of cells of human melanoma KG, secreting recombinant granulocytic
RT   macrophage colony-stimulating factor.";
RL   Patent number RU2362805, 27-Jul-2009.
//